1. Abribat, T., Chapdelaine, A., Gravel, D., Dubreuil, P., Ibea, M., Brazeau, P., 2001a. Specificity and potency of TH9507, a new growth hormone-releasing factor analogue: preclinical and clinical data. In: Proceedings of the Fifth European Congress of Endocrinology. Turin, Italy, 9–13 June, abstract O-093.
2. Abribat, T., Chapdelaine, A., Gravel, D., Brazeau, P., Aumais, C., 2001b. TH9507, a new growth hormone-releasing factor (GRF) analogue, is a powerful insulin-like growth factor-1 (IGF-1) inducer in 50–60 year old healthy subjects: a 7-day randomized multidose study. In: Proceedings of the Endocrine Society’s 83rd Annual Meeting. Denver, CO, USA, 20–23 June, abstract 292.
3. Physiology of growth hormone secretion and action;Casanueva;Endocrinol. Metab. Clin. North Am.,1992
4. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function;Clark;Endocr. Rev.,1997
5. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus;Frohman;J. Clin. Invest.,1986